Multibagger Alert: This quality pharma stock with high ROE and below industry average PE made fresh all time high on Monday

Gujarat Themis Biosyn is a high-quality pharma company displaying a high ROE of 53.66 per cent. This reflects high management efficiency.

The shares of Gujarat Themis Biosyn Ltd jumped higher by 13.74 per cent on Monday, to hit all-time highs. Gujarat Themis Biosyn is a multibagger pharmaceutical company that has soared 171 per cent in one year while in 2021 alone the stock has jumped higher by 121 per cent. In one month alone the stock is up by more than 33 per cent, outperforming the pharma sector and the markets. 

Gujarat Themis Biosyn is a high-quality pharma company displaying a high ROE of 53.66 per cent. This reflects high management efficiency. Available at a PE multiple of ~21 the stock is trading below the industry average PE. 

The financial result has been positive in the latest quarter and technically the stock is in bullish trend both in short term as well as in long term. The shares of multibagger Gujarat Themis Biosyn have consistently outperformed the pharma sector over a long term. In over 5 years the stock has jumped higher by 1021.39 per cent. 

BSE Sensex was down by more than 524 points on Monday even as the BSE Pharma index slipped by 1.70 per cent on closing basis. 

Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd.